Daniel W. Bougie

3.1k citations

61 papers · 2.0k indexed · h-index 22

Hematology top 0.5%
Surgery top 5%
Genetics top 5%
Emergency Medicine top 2%
Cardiology and Cardiovascular Medicine top 10%

Co-authors: Richard H. Aster Brian R. Curtis Janice G. McFarland Peter R. Wilker Anand Padmanabhan Curtis G. Jones James N. George Demin Wang
Topics: Platelet Disorders and Treatments (45 papers)Heparin-Induced Thrombocytopenia and Thrombosis (29 papers)Blood disorders and treatments (24 papers)
Cited by: Hematology Internal Medicine Emergency Medicine
Journals: New England Journal of Medicine Journal of the American Chemical Society Journal of Clinical Investigation
Partner nations: United States Canada Australia

In The Last Decade

Daniel W. Bougie

58 papers receiving 1.9k citations

Peers

Countries citing papers authored by Daniel W. Bougie

Since Specialization

Citations

This map shows the geographic impact of Daniel W. Bougie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel W. Bougie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel W. Bougie more than expected).

Fields of papers citing papers by Daniel W. Bougie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel W. Bougie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel W. Bougie. The network helps show where Daniel W. Bougie may publish in the future.

Co-authorship network of co-authors of Daniel W. Bougie

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel W. Bougie. A scholar is included among the top collaborators of Daniel W. Bougie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel W. Bougie. Daniel W. Bougie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluation of Ortho VITROS and Roche Elecsys S and NC Immunoassays for SARS-CoV-2 Serosurveillance Applications 2023 ·Microbiology Spectrum ·Hasan Sulaeman,Eduard Grebe,Honey Dave,(unknown),Clara Di Germanio,(unknown),(unknown),Daniel W. Bougie,(unknown),Brad J. Biggerstaff,Jefferson M. Jones,Natalie J. Thornburg,Steve Kleinman,Mars Stone,Michael P. Busch	8
2	Associations between ABO non‐identical platelet transfusions and patient outcomes—A multicenter retrospective analysis 2023 ·Transfusion ·Daniel W. Bougie,Sarah E. Reese,Rebecca Birch,(unknown),Patrick K. Mitchell,David Roh,Lisa Baumann Kreuziger,Ritchard G. Cable,Ruchika Goel,Jerome L. Gottschall,Ronald G. Hauser,Jeanne E. Hendrickson,Eldad A. Hod,Cassandra D. Josephson,(unknown),Steven Kleinman,Alan E. Mast,Paul M. Ness,Nareg H. Roubinian,Steven R. Sloan,(unknown)	9
3	Drug-Induced Immune Thrombocytopenia (DITP) Caused By Multiple Drug-Dependent Platelet-Reactive Antibodies (DDAbs) in Patients Undergoing Oxaliplatin-Containing Combination Chemotherapy for Metastatic Colon Cancer 2017 ·Blood ·Brian R. Curtis,Yen‐Michael S. Hsu,Nikolai A. Podoltsev,Jill Lacy,Susanna A. Curtis,Robert A. DeSimone,Michael S. Samuel,(unknown),Daniel W. Bougie,Richard H. Aster	0
4	A Platelet Factor 4-Dependent Platelet Activation Assay Facilitates Early Detection of Pathogenic Heparin-Induced Thrombocytopenia Antibodies 2017 ·CHEST Journal ·Curtis G. Jones,Shannon M. Pechauer,Brian R. Curtis,Daniel W. Bougie,Mehraboon S. Irani,Binod Dhakal,(unknown),Richard H. Aster,Anand Padmanabhan	17
5	IVIg for Treatment of Severe Refractory Heparin-Induced Thrombocytopenia 2017 ·CHEST Journal ·Anand Padmanabhan,Curtis G. Jones,Shannon M. Pechauer,Brian R. Curtis,Daniel W. Bougie,Mehraboon S. Irani,Barbara J. Bryant,Jack B. Alperin,Thomas G. DeLoughery,Kevin P. Mulvey,Binod Dhakal,Renren Wen,Demin Wang,Richard H. Aster	92
6	A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis 2016 ·CHEST Journal ·Anand Padmanabhan,Curtis G. Jones,Brian R. Curtis,Daniel W. Bougie,(unknown),Namrata Peswani,Janice G. McFarland,Daniel Eastwood,Demin Wang,Richard H. Aster	70
7	Recommendations for the use of the non‐obese diabetic/severe combined immunodeficiency mouse model in autoimmune and drug‐induced thrombocytopenia: communication from the SSC of the ISTH 2015 ·Journal of Thrombosis and Haemostasis ·(unknown),Jens C. Fuhrmann,Beng H. Chong,Daniel W. Bougie,Richard H. Aster	9
8	A modified PF4-dependent, CD62p expression assay selectively detects serotonin-releasing antibodies in patients suspected of HIT 2015 ·Thrombosis and Haemostasis ·Curtis G. Jones,Daniel W. Bougie,Brian R. Curtis,Janice G. McFarland,Demin Wang,Richard H. Aster,Anand Padmanabhan	21
9	Drug‐induced thrombotic microangiopathy: Experience of the Oklahoma registry and the BloodCenter of Wisconsin 2015 ·American Journal of Hematology ·Jessica Reese,Daniel W. Bougie,Brian R. Curtis,Deirdra R. Terrell,Sara K. Vesely,Richard H. Aster,James N. George	85
10	Antibodies Specific For Human Neutrophil Antigen 3a (HNA-3a) Recognize Complex Epitopes On Choline Transporter Protein 2 (CTL2): Implications For HNA-3a Antibody Detection 2013 ·Blood ·Daniel W. Bougie,Julie A. Peterson,Adam J. Kanack,Brian R. Curtis,Richard H. Aster	1
11	Structure-Guided Design of a High-Affinity Platelet Integrin α _IIb β ₃ Receptor Antagonist That Disrupts Mg ²⁺ Binding to the MIDAS 2012 ·Science Translational Medicine ·Jieqing Zhu,Won Suk Choi,(unknown),Ana Negri,Jianghai Zhu,(unknown),Jihong Li,Min Shen,Wenwei Huang,Daniel W. Bougie,Mark Rasmussen,Richard H. Aster,Craig J. Thomas,Marta Filizola,Timothy A. Springer,Barry S. Coller	73
12	Prevalence and clinical significance of low‐avidity HPA‐1a antibodies in women exposed to HPA‐1a during pregnancy 2012 ·Transfusion ·Julie A. Peterson,Adam J. Kanack,(unknown),Daniel W. Bougie,Janice G. McFarland,Brian R. Curtis,Richard H. Aster	24
13	Full‐length recombinant choline transporter–like protein 2 containing arginine 154 reconstitutes the epitope recognized by HNA‐3a antibodies 2011 ·Transfusion ·Adam J. Kanack,Julie A. Peterson,(unknown),Daniel W. Bougie,Brian R. Curtis,Richard H. Aster	8
14	New low‐frequency platelet glycoprotein polymorphisms associated with neonatal alloimmune thrombocytopenia 2009 ·Transfusion ·Julie A. Peterson,M. Gitter,Adam J. Kanack,Brian R. Curtis,Janice G. McFarland,Daniel W. Bougie,Richard H. Aster	34
15	Recurrent acute thrombocytopenia in the hospitalized patient: Sepsis, DIC, HIT, or antibiotic‐induced thrombocytopenia 2009 ·American Journal of Hematology ·(unknown),Ibrahim Aldoss,Benjamin D. Cowley,Brian R. Curtis,Daniel W. Bougie,Richard H. Aster,James N. George	43
16	Vancomycin-Induced Immune Thrombocytopenia 2007 ·New England Journal of Medicine ·Annette von Drygalski,Brian R. Curtis,Daniel W. Bougie,Janice G. McFarland,(unknown),(unknown),Kelty R. Baker,Richard H. Aster	151
17	Drug-Induced Immune Thrombocytopenia 2007 ·New England Journal of Medicine ·Richard H. Aster,Daniel W. Bougie	369
18	Patients with quinine-induced immune thrombocytopenia have both “drug-dependent” and “drug-specific” antibodies 2006 ·Blood ·Daniel W. Bougie,Peter R. Wilker,Richard H. Aster	77
19	Thrombocytopenia Resulting from Sensitivity to GPIIb-IIIa Inhibitors 2004 ·Seminars in Thrombosis and Hemostasis ·Richard H. Aster,Brian R. Curtis,Daniel W. Bougie	18
20	Immune hemolytic anemia caused by sensitivity to a metabolite of etodolac, a nonsteroidal anti‐inflammatory drug 2000 ·Transfusion ·(unknown),Raymond S. Lord,Susan T. Johnson,Peter R. Wilker,R. C. Aster,Daniel W. Bougie	16

About Daniel W. Bougie

Daniel W. Bougie is a scholar working on Hematology, Internal Medicine and Immunology and Allergy, having authored 61 papers that have together received 2.0k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (45 papers), Heparin-Induced Thrombocytopenia and Thrombosis (29 papers) and Blood disorders and treatments (24 papers). The work is most often cited by research in Hematology (1.2k citations), Internal Medicine (231 citations) and Emergency Medicine (261 citations). Daniel W. Bougie has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Richard H. Aster, Brian R. Curtis, Brian R. Curtis, Janice G. McFarland, Peter R. Wilker, Anand Padmanabhan, Curtis G. Jones, James N. George, Demin Wang and Jessica Reese. Their work appears in journals such as New England Journal of Medicine, Journal of the American Chemical Society and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact